S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › SPEC › Research report
← SPEC page
XStocksXray
Market X-Ray report · 20 October 2026

Inspecs Group plc (SPEC)

London Exchange · UK · prices in GBX · close of 20 Oct 2026

Key indicators

Last closeGBX 90.00
52-week range40.00 – 105.00
Return, 1 month / 3 months−3.7% / −6.3%
Return, 1 year / 3 years+118.2% / +15.4%
TrendAbove 200-day, below 50-day
RSI (14)2
Volatility (1 year)43.2%
Worst drawdown (1 year)-22.7%
Average daily value traded0.37M GBX
Dividend yield–

Market X-Ray price-based

58/ 100 · High confidence · ahead of 61% of stocks on this exchange
Trend68
Momentum66
Stability (higher is calmer)51
Liquidity43
Income–

Five-year price chart navy: price · brown: 200-day average

16.491192223254272021-102023-012024-042025-072026-10

About the company

Inspecs Group designs, makes and distributes spectacles and sunglasses. The company produces frames under its own brands and also supplies private-label eyewear to retail chains and optical customers. Its operations span design, manufacturing and distribution, serving opticians and retail markets in several countries. Inspecs Group is based in Bath, in the United Kingdom, and its customers include high-street retailers and optical outlets that stock its frames and sunglasses.

The shares are listed on the London Exchange in UK under the code SPEC, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Inspecs Group plc (SPEC) trades on the London Exchange in UK. It last closed at GBX 90.00 on 20 October 2026.

Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,484 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 118.2% and over the last three months it fell 6.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Inspecs Group plc (SPEC)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend68 · FairMixed trend against its averages.
Above 200-day average3.7%
From 52-week high-10.4%
Momentum66 · FairTypical recent returns for this exchange.
3-month return-6.3%
6-month return7.8%
12-month return, skipping the last month126.7%
Stability (higher is calmer)51 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)43.2%
Worst drawdown, 1 year (smaller is calmer)-22.7%
Liquidity43 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.37M GBX
Zero-volume days23.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends1

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+0.0%
1 month−3.7%
3 months−6.3%
6 months+7.8%
1 year+118.2%
3 years+15.4%
5 years−76.2%

Signals

50-day / 200-day average94.22 / 86.75
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.36

Technical summary

DailyBearish3 bullish · 3 neutral · 10 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

Recent dividends

Ex-dividend dateAmount per share
1 Sep 2022GBP 0.0125

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026